Magnevist

Gadopentetate Dimeglumine

6.7 High risk

Magnevist & Rash

42.3%

of users reported Rash

98.7%

also reported Severe reaction

58.9%

are women

Most common medical consequences

Severe reaction

98.7%

Disability

1.0%

Hospitalization

0.3%

Have you experienced any negative side effects from this medication?

Magnevist: general information

Most common side effects (19)

Most commonly affected ages

20 - 29 years

3.7%

30 - 39 years

19.3%

40 - 49 years

45.8%

50 - 59 years

22.7%

60 - 69 years

<0.1%

70 - 79 years

8.5%